These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1571826)

  • 1. Effect of salmon calcitonin and etidronate on hypercalcemia of malignancy.
    Fatemi S; Singer FR; Rude RK
    Calcif Tissue Int; 1992 Feb; 50(2):107-9. PubMed ID: 1571826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a 24-hour infusion of etidronate disodium for the treatment of hypercalcemia of malignancy.
    Flores JF; Rude RK; Chapman RA; Belani CP; Chang AY; Pritchard JD; Hoff JV
    Cancer; 1994 May; 73(10):2527-34. PubMed ID: 8174049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immobilization hypercalcemia associated with Landry-Guillain-Barré syndrome. Successful therapy with combined calcitonin and etidronate.
    Meythaler JM; Korkor AB; Nanda T; Kumar NA; Fallon M
    Arch Intern Med; 1986 Aug; 146(8):1567-71. PubMed ID: 3089187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the bisphosphonate etidronate in the therapy of cancer-related hypercalcemia.
    Singer FR
    Semin Oncol; 1990 Apr; 17(2 Suppl 5):34-9. PubMed ID: 2110387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of salmon calcitonin administered as suppositories in tumor-induced hypercalcemia.
    Thiébaud D; Burckhardt P; Jaeger P; Azria M
    Am J Med; 1987 Apr; 82(4):745-50. PubMed ID: 3565431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous etidronate in the management of malignant hypercalcemia.
    Ryzen E; Martodam RR; Troxell M; Benson A; Paterson A; Shepard K; Hicks R
    Arch Intern Med; 1985 Mar; 145(3):449-52. PubMed ID: 3919667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous disodium etidronate therapy in Paget's disease of bone and hypercalcemia of malignancy. Effects on biochemical parameters and bone histomorphometry.
    Meunier PJ; Chapuy MC; Delmas P; Charhon S; Edouard C; Arlot M
    Am J Med; 1987 Feb; 82(2A):71-8. PubMed ID: 3103438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salmon calcitonin in hypercalcemia.
    Wisneski LA; Croom WP; Silva OL; Becker KL
    Clin Pharmacol Ther; 1978 Aug; 24(2):219-22. PubMed ID: 567108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of immobilization hypercalcemia using calcitonin and etidronate.
    Meythaler JM; Tuel SM; Cross LL
    Arch Phys Med Rehabil; 1993 Mar; 74(3):316-9. PubMed ID: 8439262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonate Versus Bisphosphonate and Calcitonin for the Treatment of Moderate to Severe Hypercalcemia of Malignancy.
    Khan AA; Gurnani PK; Peksa GD; Whittier WL; DeMott JM
    Ann Pharmacother; 2021 Mar; 55(3):277-285. PubMed ID: 32885992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of calcitonin and glutocorticoids in combination on the hypercalcemia of malignancy.
    Binstock ML; Mundy GR
    Ann Intern Med; 1980 Aug; 93(2):269-72. PubMed ID: 7406378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized double-blind study of gallium nitrate compared with etidronate for acute control of cancer-related hypercalcemia.
    Warrell RP; Murphy WK; Schulman P; O'Dwyer PJ; Heller G
    J Clin Oncol; 1991 Aug; 9(8):1467-75. PubMed ID: 1906532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia.
    Sekine M; Takami H
    Oncol Rep; 1998; 5(1):197-9. PubMed ID: 9458321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on the medical treatment of hypercalcemia of malignancy.
    Hall TG; Schaiff RA
    Clin Pharm; 1993 Feb; 12(2):117-25. PubMed ID: 8453860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fast and effective treatment of malignant hypercalcemia. Combination of suppositories of calcitonin and a single infusion of 3-amino 1-hydroxypropylidene-1-bisphosphonate.
    Thiébaud D; Jacquet AF; Burckhardt P
    Arch Intern Med; 1990 Oct; 150(10):2125-8. PubMed ID: 2222097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hypercalcemia of malignancy with intravenous etidronate. A controlled, multicenter study. The Hypercalcemia Study Group.
    Singer FR; Ritch PS; Lad TE; Ringenberg QS; Schiller JH; Recker RR; Ryzen E
    Arch Intern Med; 1991 Mar; 151(3):471-6. PubMed ID: 1900410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salmon calcitonin in the acute management of hypercalcemia.
    Wisneski LA
    Calcif Tissue Int; 1990; 46 Suppl():S26-30. PubMed ID: 2137363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of clodronate and calcitonin in hypercalcemia due to malignancy.
    Ljunghall S
    Recent Results Cancer Res; 1989; 116():40-5. PubMed ID: 2527399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of oral administration of etidronate disodium in maintaining normal serum calcium levels in previously hypercalcemic cancer patients.
    Ringenberg QS; Ritch PS
    Clin Ther; 1987; 9(3):318-25. PubMed ID: 3111705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current management strategies for hypercalcemia.
    Pecherstorfer M; Brenner K; Zojer N
    Treat Endocrinol; 2003; 2(4):273-92. PubMed ID: 15966562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.